BIOTRICITY INC (BTCY)
BTCY moved a median of 0.00% 30 minutes after news, and -0.79% by the close. How BTCY actually reacts to news — the realized, point-in-time move the market made, measured across 124 labeled events over the last three years with zero look-ahead.
BTCY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 21% | 114 |
| 30-min | 0.00% | 38% | 120 |
| 60-min | 0.00% | 42% | 122 |
| to close | -0.79% | 46% | 123 |
| Middle 50% of BTCY reactions | -2.55% to +2.52% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 124 |
Half of all BIOTRICITY INC news events land between -2.55% and +2.52% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BTCY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BTCY's baseline. Nothing else.
Recent BTCY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form RW BIOTRICITY INC. | SEC filing · Form RW | SEC EDGAR | +3.25% | +2.87% | |
| Form 8-K BIOTRICITY INC. For: Sep 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.35% | |
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +5.27% | +5.27% | |
| Form NT 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | +0.00% | |
| Form 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +36.05% | |
| Form NT 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -22.90% | |
| Form DEF 14C BIOTRICITY INC. For: Jun 15 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -9.08% | |
| Form PRE 14C BIOTRICITY INC. For: May 29 | SEC filing · Form PRE | SEC EDGAR | -6.11% | -12.82% | |
| Form 8-K BIOTRICITY INC. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | -2.10% | +1.93% | |
| Form 8-K BIOTRICITY INC. For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +9.70% | |
| Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA | Press release | GlobeNewswire | +0.00% | -4.00% | |
| Form 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -4.00% | |
| Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th | Press release | GlobeNewswire | +0.00% | +0.62% | |
| Form S-1 BIOTRICITY INC. | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -13.13% | |
| Form 8-K BIOTRICITY INC. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.38% | |
| Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026 | Press release | GlobeNewswire | +0.00% | -5.46% | |
| Form 10-Q BIOTRICITY INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +1.13% | |
| Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th | Press release | GlobeNewswire | -5.36% | -1.79% | |
| Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users | Press release | PR Newswire | +1.67% | -13.33% | |
| Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform | Press release | GlobeNewswire | +0.00% | +5.78% | |
| Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins | Press release | GlobeNewswire | +0.50% | -9.55% | |
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.50% | -9.55% | |
| Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th | Press release | GlobeNewswire | — | — | |
| Form 10-K/A BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +6.24% | |
| Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach | Press release | GlobeNewswire | +28.48% | +10.43% | |
| Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th | Press release | GlobeNewswire | +0.00% | -14.44% | |
| Form 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -14.44% | |
| Form NT 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +10.63% | |
| Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed | Press release | GlobeNewswire | +3.03% | +15.19% | |
| Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management | Press release | GlobeNewswire | +12.73% | +3.96% | |
| Form 8-K BIOTRICITY INC. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +11.84% | |
| Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025 | Press release | GlobeNewswire | -1.32% | -5.16% | |
| Form 10-Q/A BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -3.23% | +3.87% | |
| Form 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.32% | -5.16% | |
| Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11% | Press release | GlobeNewswire | +4.65% | +39.53% | |
| Form NT 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +4.65% | +39.53% | |
| Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform | Press release | PR Newswire | -0.41% | +8.87% | |
| Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand | Press release | PR Newswire | +0.01% | -3.55% | |
| Biotricity Achieves Positive Free Cash Flow Milestone | Press release | PR Newswire | -0.11% | +7.42% | |
| Form 8-K BIOTRICITY INC. For: Nov 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.59% | |
| Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025 | Press release | GlobeNewswire | +25.81% | +45.32% | |
| Form 10-Q BIOTRICITY INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +25.81% | +45.32% | |
| Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th | Press release | GlobeNewswire | +0.00% | +27.59% | |
| Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins | Press release | Accesswire | -12.70% | -13.30% | |
| Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States | Press release | Accesswire | +0.00% | -7.58% | |
| Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals | Press release | Accesswire | +3.23% | -3.23% | |
| Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025 | Press release | Accesswire | +5.26% | -15.38% | |
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +15.52% | |
| Form 8-K BIOTRICITY INC. For: Aug 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.50% | |
| Form NT 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | -4.41% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BTCY section they belong to.
Where else BTCY is measured.
BTCY earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Accelerate Diagnostics, Inc. (AXDX) | 125 | -0.16% | 36% |
| GENMAB A/S (GMXAY) | 125 | 0.00% | 38% |
| CLEMENTIA PHARMACEUTICALS INC COMMON SHARES (CMTA) | 124 | +0.03% | 51% |
| DAIICHI SANKYO S/ADR (DSNKY) | 124 | -0.03% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is BIOTRICITY INC's median reaction calculated?
Every labeled BTCY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 124 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of BTCY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BTCY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.